NanoValent Pharmaceuticals' Grant

NanoValent Pharmaceuticals raised a round of funding on November 03, 2011. Investors include National Science Foundation.

NanoValent Pharmaceuticals, founded in 2010, is a privately-held company focused on the development and commercialization of a new generation, nanoparticle based, antibody-drug conjugate (ADC) technol…

Articles about NanoValent Pharmaceuticals' Grant: